drugset / Trial / NCT02591888
Impact of Liposomal Bupivacaine Administered Following Placement of a Transobturator Suburethral Sling
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Liposomal bupivacaine or placebo will be administered at the end of a transobturator midurethral sling to determine if there is a difference in a patient's perceived postoperative pain.
Timeline
- Start
- 2015-02
- Primary completion
- 2017-03
- Completion
- 2017-12
Outcome
Outcome not reported
Stopped (Enrollment): “Difficult to enroll; since a similar research project on a different population showed no significance the study has been closed.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 30 ml | — |
Indications
No indication recorded.